Skip to main content
IMUGENE LIMITED logo

IMUGENE LIMITED — Investor Relations & Filings

Ticker · IMU ISIN · AU000000IMU9 LEI · 984500A5C9KF08EAF248 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,444 across all filing types
Latest filing 2005-10-02 Regulatory Filings
Country AU Australia
Listing ASX IMU

About IMUGENE LIMITED

https://imugene.com

Imugene Limited is a clinical-stage immuno-oncology company focused on developing immunotherapies to activate the immune system against various cancers. The company’s pipeline features multiple platform technologies, including B-cell activating immunotherapies, oncolytic viruses, and CAR-T cell enhancement therapies. Key clinical candidates include HER-Vaxx, targeting HER2-positive gastric cancer, and PD1-Vaxx, a checkpoint inhibitor immunotherapy. Imugene is also advancing the CF33 oncolytic virus platform, which includes VAXINIA and CHECKvacc, alongside the onCARlytics program. The onCARlytics platform is designed to enable CAR-T cells to target solid tumors by inducing the expression of CD19 on cancer cell surfaces. These programs aim to address unmet needs in oncology by providing targeted, potent, and potentially less toxic alternatives to conventional treatments.

Recent filings

Filing Released Lang Actions
Response to ASX Share Price Query 4 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a correspondence between Imugene Limited and the Australian Stock Exchange (ASX) regarding a price query. The ASX is requesting information about recent trading activity and price changes in the company's securities, compliance with listing rules, and whether any undisclosed information could explain the trading. The document includes references to listing rules 3.1 and 17.1, continuous disclosure obligations, and trading halt procedures. There is no financial data, report, or detailed analysis present. The document is a regulatory communication responding to a market query about price movements and compliance, typical of a Regulatory Filing (RNS). The document length is 6733 characters, which is relatively short and consistent with a regulatory announcement rather than a full report. Therefore, the appropriate classification is Regulatory Filings (RNS).
2005-10-02 English
Preliminary Final Report & Full Year Accounts 62 pages ?Kb
Annual Report Classification · 95% confidence The document is titled 'Appendix 4E Preliminary final report Year ended 30 June 2005' for Imugene Limited. It contains detailed financial data including statements of financial performance, position, cash flows, and notes, as well as commentary on results and trends. The report references the audited full Financial Report for the year ended 30 June 2005 and includes comprehensive financial figures and analysis for the full fiscal year. This matches the characteristics of an Annual Report (10-K equivalent) as it covers the full fiscal year financial performance and position in detail. The document length is substantial (15,000 characters), indicating it is the report itself, not just an announcement or summary. Therefore, the correct classification is Annual Report (10-K).
2005-09-12 English
Imugene completes OGTR dossier 1 page ?Kb
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 08 September 2005 regarding Imugene completing and submitting additional information to the Office of the Gene Technology Regulator (OGTR) for a dossier related to a Poultry Productivity Enhancer. It is a regulatory update about the progress of an application and does not contain financial statements, management discussion, or detailed financial data. The document is short (1604 characters) and serves as a progress announcement rather than a full report or detailed filing. It does not fit categories like Annual Report, Interim Report, Earnings Release, or Management Reports. It is best classified as a Regulatory Filing (RNS) because it is a general regulatory announcement about the status of a regulatory application.
2005-09-07 English
Appendix 3B 8 pages ?Kb
Share Issue/Capital Change Classification · 100% confidence The document is an Appendix 3B form, which is a standard Australian Securities Exchange (ASX) form used for announcements related to new issues of securities, applications for quotation of additional securities, and agreements. It details the class and number of securities issued, exercise prices, expiry dates, and the purpose of the issue. The document does not contain financial statements or detailed financial performance data but is an official announcement regarding capital changes and securities issuance. Therefore, it fits the category of Share Issue/Capital Change announcements rather than a full financial report or other types of filings.
2005-08-25 English
Commitments Test Entity - Fourth Quarter Report 8 pages ?Kb
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Quarterly Report April-June 2005' and contains detailed operational updates, product development progress, and financial data including a consolidated statement of cash flows for the quarter ended 30 June 2005. The presence of substantive financial data and analysis for a period shorter than a full fiscal year indicates this is a comprehensive interim financial report. The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2005-07-26 English
Ceasing to be a substantial holder 3 pages ?Kb
Major Shareholding Notification Classification · 100% confidence The document is titled 'Form 605' and is a 'Notice of ceasing to be a substantial holder' under Corporations Law Section 671B. It details changes in relevant interests of a substantial holder, including dates, nature of changes, and securities affected. This type of filing is a notification about changes in significant share ownership levels, specifically when a holder ceases to be substantial. It is not a financial report, earnings release, or management information. It fits the definition of a Major Shareholding Notification, which involves notifications of changes in significant share ownership levels crossing thresholds.
2005-06-27 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.